UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): March 10, 2000

                             DHB Capital Group Inc.
                            -------------------------
             (Exact name of registrant as specified in its charter)

 Delaware                         0-22429                     11-3129361
- -------------------------      ------------                ----------------
(State or other jurisdiction   (Commission                 (IRS Employer
- ----------------------------   -----------                 -------------
   of incorporation)            File Number)               Identification No.)

                555 Westbury Avenue, Carle Place, New York    11514
            ---------------------------------------------------------
               (Address of principal executive offices)    (Zip Code)

       Registrant's telephone number, including area code: (516) 997-1155
                                                            --------------

                                 Former Address
                 (11 Old Westbury Road, Old Westbury, NY 11568)


Item 2.  Acquisition or Disposition of Assets:

         On March  10,  2000,  DHB  Capital  Group  Inc.  ("the  Company")  sold
substantially  all  of  the  assets  of  its  subsidiaries   Lanxide  Electronic
Components  Inc. and DHB KK pursuant to DMC2 Electronic  Components  Corporation
(an unrelated third party.) Both of these  subsidiaries are suppliers of silicon
carbide/aluminum  composites to the electronics industry. The purchase price was
$4,375,000 less the outstanding  loan balance of Lanxide  Electronics'  Delaware
Economic  Loan of  $141,217.  The  proceeds  of  this  sale  retired  all of the
outstanding  bank debt of the  Company to the Bank of New York.  The sales price
was determined through armslength negotiations,  at a price the Company believes
was fair:

The sale of the Lanxide Subsidiaries reflecs the Company's strategic decision to
refocus  on its  core  business,  the  design,  development  and  production  of
technologically  advanced  soft  body  armor  for  the  U.S.  Military  and  Law
Enforcement communities.


Item 7. Financial Statements and Exhibits.


        (b) Pro forma financial information

         It is impractical to provide any pro forma financial information, which
may be  required  at the time of the  filing of this  report  on Form  8-K.  The
required  pro forma  financial  financial  information  will be  included in the
Company's 10-K for the year ended  December 31, 1999,  which will be filed on or
before March 31, 2000.

        (c) Exhibits

     Unless otherwise noted the following exhibits are filed herewith:

      1      Asset Purchase Agreement
      2      Agreement on Transfer of Business



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized


                                                     DHB Capital Group, Inc.
                                                     Registrant


Date:  March 20, 2000                                /s/ Dawn M. Schlegel
                                                     -------------------
                                                     Dawn M. Schlegel,
                                                     Chief Financial Officer